Cita APA

Rodríguez Enríquez, F., Costas Lago, M., Besada, P., Alonso-Pena, M., Torres-Terán, I., Viña Castelao, M. D., . . . Terán, C. (2020). Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson’s disease therapy.

Citación estilo Chicago

Rodríguez Enríquez, Fernanda, et al. Novel Coumarin-pyridazine Hybrids As Selective MAO-B Inhibitors for the Parkinson’s Disease Therapy. 2020.

Cita MLA

Rodríguez Enríquez, Fernanda, et al. Novel Coumarin-pyridazine Hybrids As Selective MAO-B Inhibitors for the Parkinson’s Disease Therapy. 2020.